Latest News and Press Releases

Want to stay updated on the latest news?

Sign into Reader Account Create Reader Account

October 07, 2013 09:00 ET | Source: Arch Therapeutics, Inc.

Arch Therapeutics Announces Approval of $1 Million Massachusetts Life Sciences Center Accelerator Loan

WELLESLEY, MA--(Marketwired - Oct 7, 2013) - Arch Therapeutics, Inc. (OTCQB: ARTH) ("Arch" or the "Company"), a life sciences company and developer of AC5™, a novel product aimed at...